Publication Year: 2020
-
Serum proteomic score for understanding response and mechanism of resistance to immune checkpoint inhibitors in non-small cell lung cancer
-
Serum proteomic score for understanding response and mechanism of immune-related adverse events (irAE) in non-small cell lung cancer
-
Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC
-
First Look at the Distribution of Risk of Malignancy Pre and Post-Test Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study
-
Real World Performance of Blood Based Host Immune Profiling in First line Immunotherapy Treatment in Advanced Stage Non Small Cell Lung Cancer
-
Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach
-
Profiling the TCR beta repertoire in liquid biopsies from NSCLC donors